Invizius presents findings from First-In-Human Phase 1 Clinical Study of H-Guard® at UK Kidney Week

Invizius was pleased to attend UK Kidney Week, the UK’s largest conference for the professional kidney community, which was held in Edinburgh from 11-13 July. It is the annual scientific, educational, and networking meeting of the UK Kidney Association and is renowned for its up-to-date research, state-of-the-art lectures, and diverse symposia, presentations and workshops.


Dr Duha Ilyas presented the results of our recent CompAct-HD Study. Dr Liz Blackburn, Principal Scientist at Invizius, also attended the conference.


It was an exceptional opportunity for the Invizius team to engage with colleagues and other kidney specialists, and there was a lot of discussion about the ongoing effects of filter driven complement activation in Chronic Kidney Disease (CKD) patients.